Seoul Miz Hospital (서울미즈병원)
Seoul Miz Hospital (서울미즈병원)
Republic of Korea, Seoul
Dr. Lee Jihyeon is a breast and thyroid surgeon. He has expertise in benign and malignant breast diseases, oncoplastic breast surgery, and Mammotome biopsy. He also treats thyroid and parathyroid diseases. He practices pulmonary intensive care (critical care medicine).
He earned his M.D. from Yonsei University College of Medicine. He completed an internship and a general surgery residency at Yonsei University Severance Hospital. He also pursued a short-term fellowship at the Cancer Institute Hospital of JFCR in Japan.
His past roles include Chief of Surgery at Incheon Christian Hospital and Attending Surgeon at Cheil General Hospital. He served as Director of the Breast Center and as Chairman and Chief of Surgery at Samsung Cheil Hospital. He was Chairman of Surgery and Vice President of Medical Affairs at Cheil General Hospital. He also served as Clinical Professor of Surgery at Gangnam CHA Hospital, CHA University.
Fibrocystic breast changes are benign and do not increase breast cancer risk. South Korean specialists at JCI-accredited hospitals like Severance and Ewha use ultrasound. It helps distinguish cysts from lesions. Doctors there specialise in managing dense tissue common in fibrocystic cases.
Bookimed Expert Insight: South Korea leads in digital health. Seoul National University Bundang Hospital uses the global BESTcare safety system. This technology makes patients' historical imaging data instantly available to specialists. For fibrocystic patients, this means doctors can track minute tissue changes over years. They can do so with extreme precision.
Patient Consensus: Patients note that Korean clinics provide mammography and ultrasound results on the same day. They appreciate receiving digital copies and English reports for their medical records back in Australia. People also find the modern facilities and coordinated translation services helpful. They make the diagnosis process less stressful.
Surgery for fibrocystic breast disease is rarely necessary in South Korea. Specialists usually manage this benign condition with pain relief and monitoring. Doctors only consider surgical intervention for persistent or recurring lumps. Most patients receive a personalised, non-surgical plan after a thorough ultrasound examination.
Bookimed Expert Insight: South Korea's digital hospital infrastructure, seen at SNUBH, provides diagnostic precision for breast tissue. Bookimed data shows that leading clinics like Ewha Womans University Medical Center frequently offer lower-than-expected costs for examinations. This high-tech environment allows specialists to monitor fibrocystic changes accurately without rushing into invasive procedures.
Patient Consensus: Patients in South Korea value receiving clear diagnostic reports in English and having coordinators assist with hospital queues. They recommend visiting hospital-based breast units for comprehensive tissue evaluation before discussing any surgical options.
South Korean specialists diagnose fibrocystic breast disease using a triple assessment approach. This clinical process combines physical exams, high-resolution digital imaging, and biopsies. Major centres specialise in dense tissue analysis. This helps distinguish benign tissue changes from malignancies within the Korean population.
Bookimed Expert Insight: Patient volume is a major quality signal in South Korea. Seoul National University Bundang Hospital serves over 1.5 million patients annually. Their BESTcare safety system integrates digital diagnostics with surgical planning. This high volume means doctors distinguish benign fibrocystic changes from serious conditions with extreme accuracy.
Patient Consensus: Patients note the diagnostic process in South Korea is fast and highly efficient. They appreciate the focus on high-resolution imaging and the thoroughness of the specialist consultations.
Leading South Korean hospitals manage fibrocystic breast disease through diagnostic monitoring, ultrasound-guided aspiration, and hormonal therapy. Specialists use high-resolution digital imaging and fine-needle aspiration to resolve painful cysts. Facilities like Seoul National University Bundang Hospital handle over 1.5 million cases annually with precise diagnostic protocols.
Bookimed Expert Insight: While major centres like Asan Medical Center perform over 65,000 surgeries yearly, most fibrocystic cases receive conservative care. South Korean specialists often recommend Mammotome biopsies for suspicious lumps. This allows tissue removal through a tiny incision. It avoids traditional open theatre surgery and visible scarring.
Patient Consensus: Patients in South Korea value clear communication. Interpreters help navigate mammography and ultrasound appointments. Clinics also provide digital results in English for follow-up support back in Australia.
Hormonal treatments manage severe fibrocystic breast disease in South Korea by regulating oestrogen and progesterone fluctuations. Specialists prescribe oral contraceptives, synthetic steroids like Danazol, or cyclic progestin therapy. These treatments target chronic breast pain and swelling when conservative management fails to provide relief.
Bookimed Expert Insight: While major Seoul hospitals handle over 1.6 million outpatients annually, patients often benefit from the integrated approach at Ewha Womans University Medical Centre. This facility won first place in national quality rankings for three years. Their focus on women’s health means patients receive tailored hormone protocols within a 5-star multidisciplinary environment.
Patient Consensus: Patients in South Korea note that hormonal options like birth control are widely available. However, finding the right dose often requires careful monitoring and trial. Reviews from Severance Hospital highlight that even when local doctors suggest surgery, Korean oncologists frequently provide reassuring diagnoses. These are based on thorough ultrasound and mammography.
Recovery after cyst aspiration in South Korea is rapid. Most patients resume daily activities within a few hours to one day. Specialists use ultrasound guidance for a precise, minimally invasive procedure. While immediate soreness is common, it typically resolves within 24 to 48 hours.
Bookimed Expert Insight: South Korea's high patient volumes result in deep expertise in mammology. Seoul Miz Hospital alone performs 10,000+ treatments for cysts and fibroids. This experience means practitioners can distinguish simple fluid re-accumulation from complex masses during aspiration. This reduces the need for repeat visits.
Patient Consensus: Patients in South Korea describe the aspiration sensation as pressure rather than pain. They note that discomfort eases immediately once the procedure finishes. Many report feeling fully recovered within 3 days. However, mammography and ultrasound results might take up to a week.
Specialised treatment for fibrocystic breast disease in South Korea is available at centres like Ewha Womans University Medical Center and Asan Medical Center. These facilities offer diagnostics such as vacuum-assisted breast biopsy (VABB) and ultrasound-guided aspiration. Experts specialise in hormone therapy and monitoring to manage symptoms effectively.
Bookimed Expert Insight: University hospitals like Severance and Seoul National University Bundang Hospital handle 1.5 million patients annually. Even so, South Korean women's clinics often provide faster access to Mammotome biopsy. This technology allows specialists to remove entire benign lumps through a 3mm incision. It serves as both a diagnosis and a treatment.
Patient Consensus: Patients note that South Korean hospitals provide high-level service with dedicated coordinators. These coordinators assist with translations and provide reports in English. Many appreciate that costs can be lower than expected. They also value that even major check-ups typically include imaging results on a disc for follow-up back home.